Detalhe da pesquisa
1.
The prolonged clinical benefit with metronomic chemotherapy (VEX regimen) in metastatic breast cancer patients.
Anticancer Drugs
; 33(1): e628-e634, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34407044
2.
Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp-cooling system in early breast cancer patients treated with anthracyclines.
Br J Cancer
; 121(4): 325-331, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31303642
3.
Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00.
Breast Cancer Res Treat
; 158(2): 323-31, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27372069
4.
Immunohistochemically defined subtypes and outcome in occult breast carcinoma with axillary presentation.
Breast Cancer Res Treat
; 129(3): 867-75, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21822638
5.
Pegylated Liposomal Doxorubicin (Caelyx®) as Adjuvant Treatment in Early-Stage Luminal B-like Breast Cancer: A Feasibility Phase II Trial.
Curr Oncol
; 28(6): 5167-5178, 2021 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34940072
6.
Pathological complete response after preoperative systemic therapy and outcome: relevance of clinical and biologic baseline features.
Breast Cancer Res Treat
; 124(3): 689-99, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20625816
7.
Prognosis of selected triple negative apocrine breast cancer patients who did not receive adjuvant chemotherapy.
Breast
; 53: 138-142, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32795829
8.
Continuing trastuzumab beyond disease progression: outcomes analysis in patients with metastatic breast cancer.
Breast Cancer Res
; 10(4): R60, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18631394
9.
Lobular Metastatic Breast Cancer Patients With Gastrointestinal Involvement: Features and Outcomes.
Clin Breast Cancer
; 18(3): e401-e405, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28778379
10.
Metronomic Chemotherapy for First-Line Treatment of Metastatic Triple-Negative Breast Cancer: A Phase II Trial.
Breast Care (Basel)
; 13(3): 177-181, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30069178
11.
Phase II Trial of Bevacizumab Plus Weekly Paclitaxel, Carboplatin, and Metronomic Cyclophosphamide With or Without Trastuzumab and Endocrine Therapy as Preoperative Treatment of Inflammatory Breast Cancer.
Clin Breast Cancer
; 18(4): 328-335, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29486983
12.
Unfavorable prognostic role of tumor-infiltrating lymphocytes in hormone-receptor positive, HER2 negative metastatic breast cancer treated with metronomic chemotherapy.
Breast
; 34: 83-88, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28544923
13.
Safety and efficacy study of metronomic vinorelbine, cyclophosphamide plus capecitabine in metastatic breast cancer: A phase II trial.
Cancer Lett
; 400: 276-281, 2017 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28131905
14.
A meta-analysis on the interaction between HER-2 expression and response to endocrine treatment in advanced breast cancer.
Clin Cancer Res
; 11(13): 4741-8, 2005 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16000569
15.
Intermittent Letrozole Administration as Adjuvant Endocrine Therapy for Postmenopausal Women With Hormone Receptor-Positive Early Breast Cancer: A Biologic Study.
Clin Breast Cancer
; 15(5): e257-62, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26362840
16.
Outcome and Medial Presentation of Breast Cancer: European Institute of Oncology Experience.
Clin Breast Cancer
; 15(6): 440-7, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26255932
17.
Phase II Study With Epirubicin, Cisplatin, and Infusional Fluorouracil Followed by Weekly Paclitaxel With Metronomic Cyclophosphamide as a Preoperative Treatment of Triple-Negative Breast Cancer.
Clin Breast Cancer
; 15(4): 259-65, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25933934
18.
Metronomic therapy and breast cancer: a systematic review.
Cancer Treat Rev
; 40(8): 942-50, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24998489
19.
Treatment of breast cancer in young women: do we need more aggressive therapies?
J Thorac Dis
; 5 Suppl 1: S47-54, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23819027
20.
The aromatase inhibitors (plus ovarian function suppression) in premenopausal breast cancer patients: ready for prime time?
Cancer Treat Rev
; 39(8): 886-90, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23725877